Ahrens Brenton Karl
- SEC CIK
- 0001322927
No open-market purchases or sales filed in the past year.
Current role at each company
- ITRM Iterum Therapeutics plcDirectoras of Dec 28, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ahrens Brenton Karl as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 20, 2022 (view filing) | Sep 16-20 | 4 days | Ahrens Brenton KarlDirector | SSale | −37.2K | $1.82 | −$67.9K | −100.0%0 after | 3 lots |
| Sep 15, 2022 (view filing) | Sep 13-15 | 2 days | Ahrens Brenton KarlDirector | SSale | −45.0K | $2.09 | −$93.9K | −54.7%37.2K after | 3 lots |
| Sep 12, 2022 (view filing) | Sep 8-12 | 4 days | Ahrens Brenton KarlDirector | SSale | −33.3K | $2.31 | −$76.9K | −28.8%82.2K after | 3 lots |